依特鈉（股票代碼AEZS）股價財報分析

苩erna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.

依特鈉股票代碼AEZS，員工數量17人，成立日期：5/10/2000。